P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases.
Damiani
D
D
Michieli
M
M
Michelutti
A
A
Pea
F
F
Baraldo
M
M
Fanin
R
R
Russo
D
D
Furlanut
M
M
Baccarani
M
M
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000502:physiology*; D000903:Antibiotics, Antineoplastic / Q000493:pharmacokinetics*; D016572:Cyclosporine / Q000008:administration & dosage*; D018432:Drug Resistance, Multiple; D006801:Humans; D015255:Idarubicin / Q000493:pharmacokinetics*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy / Q000378:metabolism*; D007958:Leukocyte Count / Q000187:drug effects; D008297:Male; D008875:Middle Aged
D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000903:Antibiotics, Antineoplastic; D016572:Cyclosporine; D015255:Idarubicin